293 related articles for article (PubMed ID: 27311619)
1. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury with autoimmune features.
deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
Chalasani N; Li YJ; Dellinger A; Navarro V; Bonkovsky H; Fontana RJ; Gu J; Barnhart H; Phillips E; Lammert C; Schwantes-An TH; Nicoletti P; Kleiner DE; Hoofnagle JH;
J Hepatol; 2023 Feb; 78(2):293-300. PubMed ID: 36152763
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles.
Stephens C; Castiella A; Gomez-Moreno EM; Otazua P; López-Nevot MÁ; Zapata E; Ortega-Alonso A; Ruiz-Cabello F; Medina-Cáliz I; Robles-Díaz M; Soriano G; Roman E; Hallal H; Moreno-Planas JM; Prieto M; Andrade RJ; Lucena MI
Pharmacogenet Genomics; 2016 Sep; 26(9):414-22. PubMed ID: 27206238
[TBL] [Abstract][Full Text] [Related]
5. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
[TBL] [Abstract][Full Text] [Related]
7. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
8. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
9. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
10. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
[TBL] [Abstract][Full Text] [Related]
11. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
Björnsson ES; Medina-Caliz I; Andrade RJ; Lucena MI
Hepatol Commun; 2022 Aug; 6(8):1895-1909. PubMed ID: 35596597
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
Foureau DM; Walling TL; Maddukuri V; Anderson W; Culbreath K; Kleiner DE; Ahrens WA; Jacobs C; Watkins PB; Fontana RJ; Chalasani N; Talwalkar J; Lee WM; Stolz A; Serrano J; Bonkovsky HL
Clin Exp Immunol; 2015 Apr; 180(1):40-51. PubMed ID: 25418487
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case-control study in China.
Wu J; Guo N; Zhu L; Zhang X; Xiong C; Liu J; Xu Y; Fan J; Yu J; Pan Q; Yang J; Liang H; Jin X; Ye S; Wang W; Liu C; Zhang J; Li G; Jiang B; Cao H; Li L
Emerg Microbes Infect; 2020; 9(1):332-340. PubMed ID: 32037983
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
Kanzler S; Weidemann C; Gerken G; Löhr HF; Galle PR; Meyer zum Büschenfelde KH; Lohse AW
J Hepatol; 1999 Oct; 31(4):635-40. PubMed ID: 10551386
[TBL] [Abstract][Full Text] [Related]
15. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
[TBL] [Abstract][Full Text] [Related]
16. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.
Björnsson E; Talwalkar J; Treeprasertsuk S; Kamath PS; Takahashi N; Sanderson S; Neuhauser M; Lindor K
Hepatology; 2010 Jun; 51(6):2040-8. PubMed ID: 20512992
[TBL] [Abstract][Full Text] [Related]
18. Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.
Maeda Y; Migita K; Higuchi O; Mukaino A; Furukawa H; Komori A; Nakamura M; Hashimoto S; Nagaoka S; Abiru S; Yatsuhashi H; Matsuo H; Kawakami A; Yasunami M; Nakane S
PLoS One; 2016; 11(1):e0146048. PubMed ID: 26807576
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of clinical and laboratory indexes in patients with liver disease with positive anti-liver cytosol antibody].
Zhang HP; Yan HP; Lou JL; Huang CY; Ma YX; Li LJ; Han Y; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1182-1187. PubMed ID: 35045634
[No Abstract] [Full Text] [Related]
20. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
